Hsp110-mediated enhancement of CD4 T cell responses to the envelope glycoprotein of members of the family Flaviviridae in vitro does not occur in vivo
Clinical and Vaccine Immunology, ISSN: 1556-6811, Vol: 18, Issue: 2, Page: 311-317
2011
- 6Citations
- 11Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations6
- Citation Indexes6
- CrossRef4
- Captures11
- Readers11
- 11
Article Description
The use of heat shock proteins (HSP) to enhance activation of the immune response to chaperoned antigen is being explored for immunotherapy. Hsp110 chaperones large protein substrates more effectively than Hsp70, offering the potential to use complex antigens containing multiple epitopes in HSP-based vaccines. In this study, we investigated the ability of recombinant bovine Hsp110 to chaperone E2 glycoprotein, the major envelope protein of bovine viral diarrhea virus (BVDV) and the dominant target of neutralizing antibodies. Hsp110 formed complexes with E2, as demonstrated by immunoprecipitation. When monocytes from BVDV-immunized cattle were stimulated with these complexes and incubated with autologous CD4 T cells, enhanced levels of proliferation were observed. To determine the ability of these complexes to improve immunogenicity in vivo, cattle were vaccinated with either Hsp110-E2 complex or E2 only, combined with Quil-A adjuvant. In contrast to the in vitro data, cellular and humoral responses to E2 were greater in the E2-only vaccination group, indicating that complex formation had actually reduced the immunogenicity of E2. This study highlights the need for further understanding of the means by which HSP complexes are endocytosed and processed in vivo to enable the design of successful vaccine strategies. Copyright © 2011, American Society for Microbiology. All Rights Reserved.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=79551479871&origin=inward; http://dx.doi.org/10.1128/cvi.00414-10; http://www.ncbi.nlm.nih.gov/pubmed/21147937; https://journals.asm.org/doi/10.1128/CVI.00414-10; http://cvi.asm.org/lookup/doi/10.1128/CVI.00414-10; https://syndication.highwire.org/content/doi/10.1128/CVI.00414-10; https://dx.doi.org/10.1128/cvi.00414-10; https://cvi.asm.org/content/18/2/311; https://cvi.asm.org/content/18/2/311.abstract; https://cvi.asm.org/content/18/2/311.full.pdf; http://cvi.asm.org/content/18/2/311; https://journals.asm.org/doi/abs/10.1128/CVI.00414-10; http://cvi.asm.org/cgi/doi/10.1128/CVI.00414-10; http://cdli.asm.org/cgi/doi/10.1128/CVI.00414-10; https://journals.asm.org/journal/cvi; https://cvi.asm.org/content/cdli/18/2/311.full.pdf
American Society for Microbiology
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know